Dermatomyositis

Environmental Risk Factors for Myositis in Military Personnel

Environmental Risk Factors for the Anti-synthetase Syndrome

Adult and Juvenile Myositis

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study

A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis

Study of M5049 in DM and PM Participants (NEPTUNIA)

Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

Pain-Sleep in Rheumatic Disease

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

Baricitinib in Patients With Relapsing or naïve Dermatomyositis

Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

Intralesional Injection of STS in Treatment of Calcinosis

Biomarkers of Cancer-Associated Myositis